Your browser doesn't support javascript.
loading
A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation.
Och, Katharina; Turki, Amin T; Götz, Katharina M; Selzer, Dominik; Brossette, Christian; Theobald, Stefan; Braun, Yvonne; Graf, Norbert; Rauch, Jochen; Rohm, Kerstin; Weiler, Gabriele; Kiefer, Stephan; Schwarz, Ulf; Eisenberg, Lisa; Pfeifer, Nico; Ihle, Matthias; Grandjean, Andrea; Fix, Sonja; Riede, Claudia; Rissland, Jürgen; Smola, Sigrun; Beelen, Dietrich W; Kaddu-Mulindwa, Dominic; Bittenbring, Jörg; Lehr, Thorsten.
Afiliación
  • Och K; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
  • Turki AT; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany.
  • Götz KM; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
  • Selzer D; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
  • Brossette C; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Theobald S; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Braun Y; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Graf N; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Rauch J; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Rohm K; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Weiler G; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Kiefer S; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Schwarz U; Institute for Formal Ontology and Medical Information Science, Saarland University, Saarbrücken, Germany.
  • Eisenberg L; Department of Computer Science, University of Tübingen, Tübingen, Germany.
  • Pfeifer N; Department of Computer Science, University of Tübingen, Tübingen, Germany.
  • Ihle M; Averbis GmbH, Freiburg, Germany.
  • Grandjean A; Averbis GmbH, Freiburg, Germany.
  • Fix S; Averbis GmbH, Freiburg, Germany.
  • Riede C; Averbis GmbH, Freiburg, Germany.
  • Rissland J; Institute of Virology, Saarland University Medical Centre, Homburg, Germany.
  • Smola S; Institute of Virology, Saarland University Medical Centre, Homburg, Germany.
  • Beelen DW; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus, Saarbrücken, Germany.
  • Kaddu-Mulindwa D; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany.
  • Bittenbring J; Department of Internal Medicine 1, University Hospital of the Saarland, Homburg, Germany.
  • Lehr T; Department of Internal Medicine 1, University Hospital of the Saarland, Homburg, Germany.
Cancer Med ; 13(1): e6833, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38132807
ABSTRACT

BACKGROUND:

Acute graft-versus-host disease (aGvHD) is a major cause of death for patients following allogeneic hematopoietic stem cell transplantation (HSCT). Effective management of moderate to severe aGvHD remains challenging despite recent advances in HSCT, emphasizing the importance of prophylaxis and risk factor identification.

METHODS:

In this study, we analyzed data from 1479 adults who underwent HSCT between 2005 and 2017 to investigate the effects of aGvHD prophylaxis and time-dependent risk factors on the development of grades II-IV aGvHD within 100 days post-HSCT.

RESULTS:

Using a dynamic longitudinal time-to-event model, we observed a non-monotonic baseline hazard overtime with a low hazard during the first few days and a maximum hazard at day 17, described by Bateman function with a mean transit time of approximately 11 days. Multivariable analysis revealed significant time-dependent effects of white blood cell counts and cyclosporine A exposure as well as static effects of female donors for male recipients, patients with matched related donors, conditioning regimen consisting of fludarabine plus total body irradiation, and patient age in recipients of grafts from related donors on the risk to develop grades II-IV aGvHD. Additionally, we found that higher cumulative hazard on day 7 after allo-HSCT are associated with an increased incidence of grades II-IV aGvHD within 100 days indicating that an individual assessment of the cumulative hazard on day 7 could potentially serve as valuable predictor for later grades II-IV aGvHD development. Using the final model, stochastic simulations were performed to explore covariate effects on the cumulative incidence over time and to estimate risk ratios.

CONCLUSION:

Overall, the presented model showed good descriptive and predictive performance and provides valuable insights into the interplay of multiple static and time-dependent risk factors for the prediction of aGvHD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Enfermedad Injerto contra Huésped Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Enfermedad Injerto contra Huésped Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2024 Tipo del documento: Article País de afiliación: Alemania